Protagonist Therapeutics (PTGX) PT Raised to $100 at TD Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PTGX Hot Sheet
Price: $143.37 --0%
Rating Summary:
21 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 32 | New: 6
Rating Summary:
21 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 32 | New: 6
Join SI Premium – FREE
TD Cowen analyst Tara Bancroft raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $100.00 (from $90.00) while maintaining a rating.
You May Also Be Interested In
- Circle Internet Group (CRCL) PT Lowered to $100 at H.C. Wainwright
- Yamazaki Baking (2212:JP) PT Raised to JPY4,200 at Nomura/Instinet
- KakaoBank Corp (323410:KS) PT Lowered to KRW20,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
